Strengthening Our API
Advancement Platform
Our research and development (“R&D”) efforts are central to our ability to build, scale, and sustain complex manufacturing technologies across platforms
Over time, we have built R&D capabilities to further our API business by developing new products. Our R&D is also engaged in cost improvement programs These programs are run to improve the cost of goods by focusing on improving atom efficiencies, optimizing process times, reducing the process wastes, among other measures, as we focus on incremental innovation
Progress Catalyst
Our R&D team comprised 138 scientists and engineers, including 96 with master's degrees and 11 with PhDs, engaged in new product development, process innovation and complex injectables scale-up
Advancing Manufacturing
We also continue to explore the possibility of adopting more advanced technologies. One such adoption is Continuous- Flow Chemistry, an evolution from our earlier batch manufacturing process, for one of our High-Demand hormones, Progesterone, we have developed Continuous-Flow Chemistry systems .This system primarily includes continuous plug flow and thin film reactors, continuous annular centrifugal extractors and agitated thin film dryers, in addition to the solution preparation reactors. The Continuous-Flow Chemistry block at our Pithampur Facility is ready, and trials are in progress. By implementing this technology, we have reduced processing steps and increased overall yield . The Continuous-Flow Chemistry process is also expected to offer better solvent recovery, enhance safety, reduce human intervention and heighten automation.
Dedicated R&D Platforms
We operate three dedicated R&Ds
Organic Chemistry R&D
Organic chemistry R&D: Focused on Complex Synthesis, including Photochemistry, Cryogenic and Grignard Chemistry, and Continuous Flow Chemistry, aimed at reducing solvent usage and improving cost and time efficiency
Facilitated With
- Photo-Reactors,
- High-Performance Liquid Chromatography and Ultra-performance Liquid Chromatography Systems for High-Resolution Separation and Analysis
- Liquid Chromatography-Mass Spectrometry and Inductively Coupled Plasma Mass Spectrometry for Highly Sensitive Molecular and Elemental Characterization
- We Also Utilize Preparative High-Performance Liquid Chromatography For Compound Purification at Scale
.webp)
Biotechnology R&D
Encompassing recombinant Protein Expression and Synthetic Biology, with applications in Biosimilars, Insulin Analogues, and Fermentation-Based Nutraceuticals such as Dietary Supplements, Alternate Proteins and Functional Foods
Facilitated With
- Polymerase Chain Reaction Systems for precise genetic analysis
- Nucleic acid extractors for efficient and reliable isolation of DNA and RNA
- Preparatory Scale High-Performance Liquid Chromatography Systems for purification
Complex Injectables R&D
Concentrated on developing differentiated Injectables, including Active Freeze-Drying (AFD), Double-Chamber Platforms and Proprietary Packaging Solutions
Facilitated With
- Vial Washing and Tunnel
- Vial Filling Machine, Isolator
- Lyophilizer
- Autoclave
Regulatory Filings & DMF
Through our R&D efforts, as of 30 June 2025, we held 42 DMFs Registered with the US FDA and 23 CEPs from the EDQM
Analytical Support
End-to-end analytical method development, validation, and stability studies supporting global regulatory submissions
Validation Support
Process, cleaning, and analytical validations aligned with global compliance standards to ensure consistent quality
Regulatory Support
Strong regulatory strategy and documentation support for DMFs, CEPs, and global health authority filings